VOLORIDGE INVESTMENT MANAGEMENT, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 236 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$26,019,760
+3.6%
1,601,216
+17.9%
0.10%
+5.4%
Q1 2024$25,108,921
-37.5%
1,357,973
+5.9%
0.09%
-41.8%
Q4 2023$40,144,962
+84.4%
1,282,177
+22.8%
0.16%
+47.7%
Q3 2023$21,767,401
+76.6%
1,044,501
+103.0%
0.11%
+84.5%
Q2 2023$12,324,047
+203.3%
514,574
+138.3%
0.06%
+190.0%
Q1 2023$4,063,840
-49.5%
215,932
-57.2%
0.02%
-55.6%
Q4 2022$8,041,256
-30.2%
505,104
-28.3%
0.04%
-27.4%
Q3 2022$11,527,000
-21.5%
704,565
-32.4%
0.06%
-18.4%
Q2 2022$14,685,000
+42.8%
1,042,255
+145.4%
0.08%
+31.0%
Q1 2022$10,285,000
+35.2%
424,661
+30.3%
0.06%
+38.1%
Q4 2021$7,607,000
-40.5%
325,913
-57.7%
0.04%
-48.8%
Q3 2021$12,784,000
-12.7%
769,672
+28.2%
0.08%
-19.6%
Q2 2021$14,645,000
-11.2%
600,432
-6.1%
0.10%
-15.0%
Q1 2021$16,496,000
+339.2%
639,364
+512.7%
0.12%
+84.6%
Q3 2019$3,756,000
+1055.7%
104,352
+758.2%
0.06%
+622.2%
Q2 2019$325,000
-64.2%
12,160
-64.0%
0.01%
-66.7%
Q1 2019$907,00033,7780.03%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 647,833$26,723,00011.32%
GREAT POINT PARTNERS LLC 1,921,563$79,264,0007.13%
Baker Brothers Advisors 41,904,586$1,728,564,0006.91%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 486,000$20,048,0006.47%
Palo Alto Investors LP 1,832,300$75,582,0004.15%
Birchview Capital, LP 204,000$8,416,0002.81%
SECTORAL ASSET MANAGEMENT INC 556,514$22,956,0001.97%
Rock Springs Capital Management LP 1,573,200$64,895,0001.65%
Riggs Asset Managment Co. Inc. 17,470$2,025,0000.85%
PFM Health Sciences, LP 421,087$17,370,0000.80%
View complete list of ACADIA PHARMACEUTICALS INC shareholders